Feasibility Study of PVC/PE Composite Films in Pharmaceutical Blister Packaging

In the pharmaceutical industry, polyvinyl chloride (PVC) films are widely used for blister packaging due to their low cost and excellent thermoforming properties. However, standard PVC has well-known drawbacks: poor moisture and oxygen barrier properties, alongside environmental concerns regarding its chlorine content. While high-barrier alternatives like PVDC, or alternative polymers like PP and PET, have been developed, they often suffer from inferior processability and productivity compared to PVC, and their adoption typically requires costly modifications to existing blister packaging machines.

To address these challenges, this study explores the feasibility of using PVC/PE composite films—combining a structural PVC layer with an inner polyethylene (PE) layer—to enhance product safety while maintaining compatibility with current blister lines.


1. Material Structure and Test Setup

Material Specifications

  • PVC/PE Composite Film: Total thickness of 0.3 mm, comprising a 0.25 mm PVC structural layer and a 0.05 mm PE inner layer. The PE layer faces inward to prevent direct contact between the medicine and PVC, while ensuring optimal heat-sealing with PTP aluminum foil.
  • PTP Aluminum Foil: Utilizes an eco-friendly hot-melt adhesive composed mainly of water-borne polyurethane and polyolefin, replacing traditional VC adhesives.
  • Equipment: Standard industrial blister packaging machine.

Testing Methodology

  • Barrier Performance: Oxygen and water vapor permeance tests were conducted on composite film samples.
  • Thermal Sealing Strength: Samples (100 mm × 260 mm) were sealed at 150 °C ± 5 °C under 0.4 MPa pressure for 1 second. After 12 hours at room temperature, 15 mm strips were pulled at a 180° angle using a universal tensile tester.
  • Machine Operational Test: Full-scale trials (15,000 sheets across 3 operational shifts) were performed, adjusting foil rolling directions to ensure the PE layer contacted the PTP aluminum foil’s adhesive side.
  • Tightness & Altitude Simulation: 60 boxes (200 sheets/box) were transported from low to high-altitude/low-pressure regions; samples were then tested at 0.08 MPa negative pressure for 30 seconds to check for water ingress.

2. Test Results and Engineering Analysis

A. Barrier Performance

Because the aluminum foil lid provides exceptional metal-level protection, the overall package barrier primarily depends on the forming film. Test results successfully met standard pharmaceutical thresholds:

  • Oxygen Permeance: 30 cm³/(m² · 24h · 0.1MPa).
  • Water Vapor Permeance: 2.5 g/(m² · 24h) (benchmarked against YBB00212005 standards for solid drug PVC films).

B. Thermal Sealing Strength

Seal integrity is vital for product protection. The average thermal sealing strength reached 9.5 N/15 mm, comfortably surpassing the standard requirement of ≥ 7 N/15 mm.

C. Machine Adjustments and Thermal Parameters

  • Temperature Zoning: Due to differing softening points, upper heating plate temperatures (PE side) must be reduced, while lower heating plate temperatures (PVC side) must be increased.
  • Roller Flexibility: Replacing traditional VC adhesive with polyolefin increases foil friction, requiring smoother movement and lower resistance across all guide rollers, alongside a slightly elevated sealing temperature.

3. Conclusion and Practical Considerations

Laboratory and production-line testing confirm that PVC/PE composite films and modified aluminum foils are technically viable for mass production, offering superior safety since the inert PE layer directly contacts the drug rather than PVC.

However, packaging engineers should account for two practical trade-offs during implementation: an increase in material cost due to the extra lamination process, and a slight reduction in optical transparency caused by the PE layer.

(Jornen Machinery)